J&J case signals employee drug price suits to come

By Bloomberg Law
| February 09, 2024

A novel lawsuit from an employee suing J&J for allegedly mismanaging drug benefits appears a harbinger of litigation to come against companies, especially those that rely on PBMs to negotiate pricing and rebates.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...